The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
How Will The Market Value Of The Toxicology Drug Screening Market Change Between 2026 And 2030?
The toxicology drug screening market size has shown substantial growth over recent years. This market is projected to expand from $21.44 billion in 2025 to $23.5 billion in 2026, indicating a compound annual growth rate (CAGR) of 9.6%. During the historic period, this growth was driven by factors such as a reliance on manual toxicology testing methods, limited laboratory automation, the increasing prevalence of substance abuse monitoring, rising regulatory oversight, and the adoption of conventional bioanalytical instrumentation.
The toxicology drug screening market is anticipated to experience substantial expansion over the coming years. It is projected to reach $33.48 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.2%. This growth during the forecast period can be primarily attributed to the emergence of AI-driven predictive toxicology solutions, the incorporation of genomics and transcriptomics into screening processes, the expansion of contract research organizations (CROs), an increasing need for real-time drug monitoring systems, and the adoption of cloud-based, secure data management platforms. Key trends anticipated within this period encompass the increasing embrace of high-throughput screening technologies, the integration of LIMS and other laboratory information systems, the escalating utilization of predictive and AI-powered toxicology platforms, the broadening scope of workplace drug screening initiatives, and a heightened emphasis on data security and compliance standards.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24728&type=smp
What Key Growth Drivers Are Influencing The Toxicology Drug Screening Market?
An increase in drug abuse cases is projected to boost the expansion of the toxicology drug screening market. Drug abuse involves the detrimental or overuse of substances for non-medical reasons, adversely affecting an individual’s health and quality of life. The escalating incidence of drug abuse stems from heightened stress and mental health issues, prompting numerous people to turn to substance misuse as a coping mechanism. Toxicology drug screening proves beneficial in addressing drug abuse by facilitating the detection of drugs or their breakdown products within an individual’s system, thereby allowing for prompt identification, diagnosis, and ongoing oversight of substance misuse or potential overdose. As an illustration, in August 2024, data from the National Records of Scotland (NRS), a government body in Scotland, revealed that Scotland documented 1,172 drug misuse deaths in 2023, representing a 12% increase (121 additional deaths) compared to the figures from 2022. Consequently, the increasing occurrence of drug abuse acts as a key stimulant for the toxicology drug screening market.
What Segment Types Are Included In The Toxicology Drug Screening Market Analysis?
The toxicology drug screening market covered in this report is segmented –
1) By Type: Screening Assays, Analytical Confirmatory Tests, Sample Collection Devices, Laboratory Consumables, Rapid Point-of-Care Tests, Laboratory Software And Reporting Systems
2) By Test Type: Acute Systemic Toxicity, Dermal Toxicity, Carcinogenicity, Ocular Toxicity, Genotoxicity, Neurotoxicity, Organ-Specific Toxicity
3) By Technology Type: High-Throughput Screening, Genomics, Transcriptomics, Toxicogenomics, Molecular Screening
4) By Application: Immunotoxicity, Systemictoxicity, Developmental And Reproductive Toxicity (DART), Endocrine Disruption, Other Applications
5) By End Users: Hospitals, Clinics, Contract Research Organizations (CROs), Pharmaceutical Companies, Workplace Testing Facilities
Subsegments:
1) By Screening Assays: Immunoassay Drug Screening Kits, Enzyme-Linked Immunosorbent Assay (ELISA) Kits, Lateral Flow Rapid Screening Assays, Fluorescence Polarization Immunoassays
2) By Analytical Confirmatory Tests: Gas Chromatography–Mass Spectrometry (GC-MS), Liquid Chromatography–Mass Spectrometry (LC-MS/MS), High-Performance Liquid Chromatography (HPLC), Capillary Electrophoresis Toxicology Tests
3) By Sample Collection Devices: Urine Drug Collection Cups, Saliva (Oral Fluid) Collection Devices, Blood Collection Tubes, Hair Drug Collection Kits
4) By Laboratory Consumables: Calibrators And Controls, Reagents And Buffers, Extraction Cartridges And Columns, Sample Preparation Kits
5) By Rapid Point-of-Care Tests: Multi-Panel Urine Dip Cards, Saliva Drug Screening Cassettes, Breath Alcohol And Drug Screening Devices, Single-Drug Detection Test Strips
6) By Laboratory Software And Reporting Systems: Laboratory Information Management Systems (LIMS), Toxicology Reporting And Result Interpretation Software, Chain-of-Custody Tracking Software, Compliance And Audit Documentation Systems
Which Trends Are Shaping The Toxicology Drug Screening Market Landscape?
Leading companies in the toxicology drug screening market are concentrating on introducing innovative solutions, such as the 3D liver microphysiological system, which facilitates the culturing of highly biomimetic human liver microtissues with organized cell arrangements and active metabolic function. The 3D liver microphysiological system (MPS) stands as an advanced in vitro platform, meticulously designed to replicate the physiological microenvironment of the human liver more accurately than traditional cell culture methods, typically involving the cultivation of multiple types of human liver cells. For example, in February 2025, CN Bio Innovations Ltd., a U.K.-based life sciences company specializing in the development of organ-on-a-chip (OOC) technologies, launched the PhysioMimix DILI assay kit. This all-in-one laboratory kit is developed for the in vitro profiling of human drug-induced liver injury and features a highly characterized 3D liver microphysiological system (MPS) that recreates metabolically active, highly functional human liver tissue and Kupffer cells. Additionally, it offers effortless adoption of organ-on-a-chip technology with a plug-and-play format, simplifying implementation and reducing the time to adoption.
Which Companies Are Influencing The Toxicology Drug Screening Market?
Major companies operating in the toxicology drug screening market are Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Merck KGaA, Siemens Healthineers, BD Bioscience, Quest Diagnostics, ICON plc, Agilent Technologies Inc., Eurofins Scientific SE, Wuxi AppTec, Charles River Laboratories International Inc., Shimadzu Corporation, Waters Corporation, Bio-Rad Laboratories Inc., Bruker Corporation, Evotec AG, Promega Corporation, The Jackson Laboratory, Clinical Reference Laboratory Inc., Enzo Life Sciences Inc., Covance Inc., Randox Toxicology, Alere Inc.
Access The Complete Toxicology Drug Screening Market Report:
https://www.thebusinessresearchcompany.com/report/toxicology-drug-screening-global-market-report
Which Region Is The Dominant Market In The Toxicology Drug Screening Market?
North America was the largest region in the toxicology drug screening market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the toxicology drug screening market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Toxicology Drug Screening Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/sample.aspx?id=24728&type=smp
Browse Through More Reports Similar to the Global Toxicology Drug Screening Market 2026, By The Business Research Company
In Vitro Toxicology Testing Market Report 2026
https://www.thebusinessresearchcompany.com/report/in-vitro-toxicology-testing-global-market-report
Adme Toxicology Testing Market Report 2026
https://www.thebusinessresearchcompany.com/report/adme-toxicology-testing-global-market-report
Artificial Intelligence Ai In Predictive Toxicology Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model